LTBR acts as a novel immune checkpoint of tumor-associated macrophages for cancer immunotherapy
{{output}}
Tumor-associated macrophages (TAMs) greatly contribute to immune checkpoint inhibitor (ICI) resistance of cancer. However, its underlying mechanisms and whether TAMs can be promising targets to overcome ICI resistance remain to be unveiled. Through integrative... ...
